冠状病毒Coronavirusl论文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf

冠状病毒Coronavirusl论文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf

ID:50643582

大小:280.60 KB

页数:7页

时间:2020-03-16

冠状病毒Coronavirusl论文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第1页
冠状病毒Coronavirusl论文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第2页
冠状病毒Coronavirusl论文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第3页
冠状病毒Coronavirusl论文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第4页
冠状病毒Coronavirusl论文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf_第5页
资源描述:

《冠状病毒Coronavirusl论文-2013 Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit.pdf》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、VIRALIMMUNOLOGYOriginalArticlesVolume26,Number2,2013ªMaryAnnLiebert,Inc.Pp.126–132DOI:10.1089/vim.2012.0076ImmunogenicityandProtectionEfficacyofMonomericandTrimericRecombinantSARSCoronavirusSpikeProteinSubunitVaccineCandidates1,22221JieLi,LauraUlitzky,EricaSilbe

2、rstein,DeborahR.Taylor,andRaphaelViscidiAbstractSevereacuterespiratorysyndrome(SARS)isanewlyemerginginfectiousdisease,andaneffectivevaccineisnotavailable.Inthisstudy,wecomparedtheimmunogenicityandprotectionefficacyofrecombinantproteinscorrespondingtodifferentdom

3、ainsoftheSARS-coronavirusspikeprotein.TrimericrecombinantproteinswerecreatedbyfusingthefoldondomainderivedfromT4bacteriophagetothecarboxy-terminiofindividualdo-mainsofthespikeprotein.Whilethefull-lengthectodomain(S)ofthespikeprotein,thefull-lengthectodomainfuse

4、dtofoldon(S-foldon),theS1domain(S1),S1-foldon,andtheS2domain(S2)antigensallelicitedcomparableantibodytitersasmeasuredbyELISA,S-foldoninducedasignificantlyhighertiterofneutralizingantibodyandS2proteindidnotelicitvirusneutralizingantibodies.Whentestedinamousevirus

5、replicationmodel,allthemicevaccinatedwiththeS1,S1-foldon,S,orS-foldonwerecompletelyprotected.IntroductionsideredamaintargetforSARSvaccines(6).Inthepresentstudy,wecomparedthefull-lengthectodomainofSproteinSevereacuterespiratorysyndrome(SARS)-associatedanditsfrag

6、ments(S1andS2domains)withrespecttoim-coronavirus(SARS-CoV)isanemerginginfectiouspath-munogenicityandprotectionagainstviralinfectioninmice.ogenofzoonoticorigin.AlthoughnonewcasesofSARShaveInitsnativestate,Sproteinisatrimer;however,whenitsbeenreportedsince2004,SA

7、RShasthepotentialtore-emergeectodomainisexpressedasarecombinantproteinineu-fromananimalreservoirorthroughaccidentalorintentionalkaryoticsystems,theproteinexistspredominantlyinamo-release.Therefore,thedevelopmentofeffectivevaccinesisnomericform(7).Tomaketrimeric

8、recombinantspikehighlydesirableforthepreventionandcontainmentoffutureproteins,weexploiteda27-aminoacidsequence,calledtheoutbreaksofSARS.foldondomain,whichwasidentifiedintheba

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。